Akebia Therapeutics, Inc. Quarterly Common Stock, Shares Authorized from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Akebia Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2013 to Q3 2024.
  • Akebia Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 350M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 350M 0 0% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 350M 0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 350M 0 0% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 350M 0 0% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 350M 0 0% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 350M 0 0% Jun 30, 2023 10-Q 2023-08-28
Q1 2023 350M 0 0% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 350M 0 0% Dec 31, 2022 10-K 2024-03-14
Q3 2022 350M 0 0% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 350M 0 0% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 350M 0 0% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 350M 0 0% Dec 31, 2021 10-K/A 2023-08-28
Q3 2021 350M 0 0% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 350M 0 0% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 350M +175M +100% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 350M +175M +100% Dec 31, 2020 10-K 2022-03-01
Q3 2020 350M +175M +100% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 350M +175M +100% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 175M 0 0% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 175M 0 0% Dec 31, 2019 10-K 2021-02-25
Q3 2019 175M 0 0% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 175M 0 0% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 175M 0 0% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 175M 0 0% Dec 31, 2018 10-K 2020-03-12
Q3 2018 175M 0 0% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 175M 0 0% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 175M 0 0% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 175M 0 0% Dec 31, 2017 10-K 2019-03-26
Q3 2017 175M 0 0% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 175M 0 0% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 175M 0 0% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 175M 0 0% Dec 31, 2016 10-K 2018-03-12
Q3 2016 175M 0 0% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 175M 0 0% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 175M 0 0% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 175M 0 0% Dec 31, 2015 10-K 2017-03-06
Q3 2015 175M 0 0% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 175M 0 0% Jun 30, 2015 10-Q 2015-08-11
Q1 2015 175M 0 0% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 175M +160M +1090% Dec 31, 2014 10-K 2017-03-06
Q3 2014 175M Sep 30, 2014 10-Q 2014-11-10
Q2 2014 175M Jun 30, 2014 10-Q 2014-08-11
Q1 2014 175M Mar 31, 2014 10-Q 2014-05-12
Q4 2013 14.7M Dec 31, 2013 10-K 2015-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.